WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
CN Stock MarketDetailed Quotes
605016 Shandong Bailong Chuangyuan Bio-Tech
- 19.11
- -2.12-9.99%
Market Closed Apr 3 15:00 CST
6.17BMarket Cap26.36P/E (TTM)
20.98High19.11Low89.96KlotVolume20.80Open21.23Pre Close175.24MTurnover2.78%Turnover Ratio32.01P/E (Static)323.09MShares23.7352wk High3.82P/B6.17BFloat Cap14.4952wk Low23.35Limit Up323.09MShs Float23.73Historical High19.11Limit Down8.81%Amplitude6.52Historical Low0.24Dividend TTM19.48Avg Price52.23KlotAsk1.23%Div YieldTTM100Lot Size31.08KlotBid
Shandong Bailong Chuangyuan Bio-Tech Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -35.27%183.35M | -19.32%206.79M | -19.29%251.23M | -8.25%175.87M | 18.19%283.24M | -2.66%256.3M | -0.41%311.29M | -37.20%191.69M | 4.99%239.65M | -50.93%263.3M |
| Transactional financial assets | 7.01%225.31M | -10.79%250.5M | 3.13%242.13M | -23.42%252.7M | -20.79%210.55M | 15.55%280.78M | 17.98%234.79M | 32.88%330M | -9.89%265.81M | --243M |
| Notes receivable and accounts receivable | 31.63%257.71M | 42.50%243.67M | 11.88%197.51M | 11.01%169.43M | 31.72%195.77M | 7.81%171M | -3.51%176.54M | 6.27%152.63M | -15.58%148.63M | -6.68%158.61M |
| -Notes receivable | -58.00%419.98K | -0.34%3.91M | 446.61%1.37M | 8.14%2.22M | 1,023.60%1M | 312.29%3.92M | -80.90%250K | 26.96%2.06M | -92.15%89K | -66.04%950.78K |
| -Accounts receivable | 32.09%257.29M | 43.50%239.77M | 11.26%196.14M | 11.04%167.2M | 31.13%194.77M | 5.98%167.08M | -2.95%176.29M | 6.04%150.57M | -15.08%148.54M | -5.68%157.66M |
| Other receivables (including interest and dividends) | 43.87%8.01M | 161.09%8.91M | 208.08%7.23M | 119.82%4.85M | 453.68%5.57M | 42.44%3.41M | -22.72%2.35M | 52.10%2.21M | -65.76%1.01M | -42.43%2.4M |
| -Other receivable | ---- | 161.09%8.91M | ---- | ---- | ---- | 42.44%3.41M | ---- | 52.10%2.21M | ---- | -42.43%2.4M |
| Advance payment | -9.05%20.79M | 30.42%21.79M | -9.47%17.97M | 34.28%9.57M | 70.82%22.86M | -7.01%16.71M | -26.31%19.85M | 16.89%7.12M | -3.61%13.38M | 99.07%17.97M |
| Inventories | 19.72%158.23M | 5.52%146.25M | -1.47%155.3M | -9.34%152.05M | -13.72%132.18M | -7.46%138.59M | 19.81%157.62M | 37.67%167.71M | 62.88%153.19M | 55.73%149.77M |
| Other current assets | 920.14%3.22M | -70.79%1.01M | 326.42%10.48M | 121.87%9.27M | -60.02%315.62K | 226.38%3.45M | 332.49%2.46M | -21.41%4.18M | -74.38%789.39K | -76.35%1.06M |
| Total current assets | 0.72%856.61M | 0.99%878.91M | -2.55%881.85M | -9.56%773.74M | 3.41%850.47M | 4.08%870.26M | 5.63%904.89M | 2.84%855.54M | 1.13%822.45M | 1.92%836.11M |
| Non Current assets | ||||||||||
| Other equity investment | 0.13%58.98M | 0.13%58.98M | 0.13%58.98M | 0.13%58.98M | -1.25%58.9M | 3.04%58.9M | 3.04%58.9M | 3.04%58.9M | 5.39%59.65M | 1.00%57.17M |
| Fixed assets | ---- | 205.16%874.04M | ---- | ---- | ---- | -12.82%286.42M | ---- | -13.07%306.09M | ---- | -8.69%328.54M |
| Constru in process | ---- | -86.57%33.08M | ---- | ---- | ---- | 523.92%246.36M | ---- | 1,029.68%193.36M | ---- | 374.66%39.49M |
| Intangible assets | 240.06%48.72M | 27.53%18.45M | 27.27%18.58M | -3.75%14.19M | -3.74%14.33M | -3.73%14.46M | -3.74%14.6M | -3.73%14.74M | -3.72%14.88M | -3.82%15.02M |
| Development expenditure | --3.04M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Long deferred expense | 583.16%15.53M | 1.89%2.08M | 72.19%2.45M | 96.90%2.42M | 28.10%2.27M | 14.46%2.04M | -28.74%1.43M | -30.71%1.23M | 60.50%1.77M | 64.52%1.78M |
| Deferred tax assets | 15.68%2.72M | 15.68%2.72M | -97.62%2.64M | -7.49%2.39M | -7.79%2.35M | -7.79%2.35M | 4,198.22%110.61M | 0.28%2.58M | 11.14%2.55M | 11.14%2.55M |
| Usufruct assets | 22.98%2.89M | 115.18%3.34M | 192.29%3.79M | 25.58%1.94M | 195.69%2.35M | 62.73%1.55M | 16.50%1.3M | 21.10%1.54M | --795.94K | --955.13K |
| Other non current assets | -81.88%37.06M | -72.73%31.57M | 1,942.03%52.69M | 27.62%48.45M | 130.16%204.54M | 34.58%115.77M | -94.67%2.58M | 1,052.28%37.96M | 880.17%88.87M | 2,321.65%86.03M |
| Total non current assets | 33.16%1.07B | 40.72%1.02B | 56.51%1B | 59.06%980.44M | 38.52%804.1M | 36.94%727.86M | 32.55%641.79M | 36.79%616.41M | 29.28%580.49M | 18.84%531.53M |
| Total assets | 16.49%1.93B | 19.09%1.9B | 21.96%1.89B | 19.17%1.75B | 17.94%1.65B | 16.85%1.6B | 15.35%1.55B | 14.77%1.47B | 11.14%1.4B | 7.89%1.37B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 40.00%70M | 40.00%70M | 20.00%60M | ---- | 4,900.00%50M | 4,900.00%50M | 4,900.00%50M | ---- | -93.75%1M | -97.62%1M |
| Notes payable and accounts payable | 70.57%200.75M | 104.90%224.82M | 175.95%204.98M | 130.22%214.89M | 121.42%117.7M | 78.80%109.72M | -1.23%74.28M | 102.70%93.34M | 28.52%53.16M | 32.52%61.36M |
| -Notes payable | 35.14%78.19M | -7.49%57.67M | 317.15%69.11M | 164.59%27.94M | 165.66%57.86M | 150.14%62.34M | -14.51%16.57M | -23.06%10.56M | 51.85%21.78M | 75.22%24.92M |
| -Accounts payable | 104.82%122.56M | 252.76%167.15M | 135.42%135.86M | 125.83%186.95M | 90.71%59.84M | 30.02%47.38M | 3.38%57.71M | 156.10%82.78M | 16.14%31.38M | 13.59%36.44M |
| Contract liabilities | 38.01%2.9M | -1.65%6M | -48.61%1.94M | -29.10%2.89M | -67.81%2.1M | 50.89%6.1M | -43.75%3.78M | -40.88%4.07M | 2.05%6.54M | 54.92%4.04M |
| Salaries payable | 38.83%6.56M | 46.03%6.79M | 41.51%5.67M | -2.46%9.55M | 16.64%4.73M | 13.19%4.65M | -2.47%4.01M | 52.11%9.79M | 2.33%4.05M | 14.63%4.11M |
| Taxs payable | 6.68%10.03M | -2.02%9.3M | 16.98%9.99M | 28.70%8.3M | 92.31%9.4M | 23.40%9.49M | 28.14%8.54M | 60.31%6.45M | 25.81%4.89M | 68.26%7.69M |
| Other payable (including interest and dividends) | 27.53%9.84M | 90.18%11.45M | 243.03%34.48M | -20.73%5.03M | -43.81%7.72M | -46.09%6.02M | 306.50%10.05M | 4.48%6.35M | 43.33%13.73M | 25.08%11.17M |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.36M |
| -Other payable | ---- | 90.18%11.45M | ---- | ---- | ---- | 3.65%6.02M | ---- | 4.48%6.35M | ---- | -34.94%5.81M |
| Non current liabilities due within one year | 24.07%1.32M | 63.13%1.66M | 11.76%1.03M | -6.42%1.03M | 38.60%1.06M | 34.01%1.02M | --925.11K | 49.36%1.1M | --766.5K | --757.47K |
| Total current liabilities | 56.41%301.41M | 76.48%330.01M | 109.84%318.09M | 99.57%241.7M | 129.05%192.71M | 107.47%186.99M | 70.63%151.59M | 70.06%121.11M | 3.62%84.13M | -17.47%90.13M |
| Current liabilities | ||||||||||
| Deferred tax liabilities | 0.44%2.58M | 0.44%2.58M | 11.76%2.87M | 1.50%2.62M | 11.29%2.57M | 11.29%2.57M | 11.29%2.57M | 11.89%2.58M | 3.84%2.31M | 3.84%2.31M |
| Long term deferred income | -64.48%640.01K | -59.10%896.91K | -49.24%1.31M | -52.58%1.41M | -42.69%1.8M | -40.22%2.19M | -38.51%2.58M | -37.44%2.97M | -40.78%3.14M | -38.29%3.67M |
| Lease liabilities | 22.74%1.68M | 298.08%1.94M | 392.52%2.67M | 81.74%627.32K | 586.28%1.37M | 22.90%486.32K | -58.38%541.41K | -55.50%345.18K | --199.02K | --395.69K |
| Total non current liabilities | -14.65%4.89M | 3.15%5.41M | 20.29%6.85M | -21.07%4.66M | 1.51%5.73M | -17.65%5.24M | -27.12%5.69M | -24.71%5.9M | -24.98%5.65M | -21.99%6.37M |
| Total liabilities | 54.35%306.3M | 74.48%335.42M | 106.60%324.94M | 93.97%246.35M | 121.03%198.44M | 99.21%192.24M | 62.74%157.28M | 60.67%127.01M | 1.20%89.78M | -17.79%96.5M |
| Shareholders equity | ||||||||||
| Paid-in capital | 30.00%323.09M | 30.00%323.09M | 40.00%248.53M | 40.00%248.53M | 40.00%248.53M | 96.00%248.53M | 40.00%177.52M | 40.00%177.52M | 40.00%177.52M | 0.00%126.8M |
| Capital reserve funds | -14.65%434.23M | -14.65%434.23M | -12.25%508.79M | -12.25%508.79M | -12.25%508.79M | -19.31%508.79M | -8.04%579.8M | -8.04%579.8M | -8.04%579.8M | 0.00%630.52M |
| Surplus reserve funds | 32.32%79.09M | 32.32%79.09M | 32.32%79.09M | 32.32%79.09M | 33.74%59.78M | 33.74%59.78M | 33.74%59.78M | 33.74%59.77M | 30.51%44.7M | 30.51%44.7M |
| Retained profit | 23.31%770.06M | 24.81%716.73M | 27.36%710.36M | 27.96%656.81M | 26.01%624.49M | 25.92%574.25M | 29.98%557.77M | 32.17%513.31M | 34.16%495.59M | 31.76%456.06M |
| Other composite income | 0.44%14.6M | 0.44%14.6M | 0.44%14.6M | 0.44%14.6M | -6.47%14.54M | 11.29%14.54M | 11.29%14.54M | 11.29%14.54M | 23.57%15.55M | 3.84%13.06M |
| Shareholders equity without minority interests | 11.33%1.62B | 11.51%1.57B | 12.38%1.56B | 12.11%1.51B | 10.89%1.46B | 10.60%1.41B | 11.67%1.39B | 11.76%1.34B | 11.90%1.31B | 10.51%1.27B |
| Total shareholder equity | 11.33%1.62B | 11.51%1.57B | 12.38%1.56B | 12.11%1.51B | 10.89%1.46B | 10.60%1.41B | 11.67%1.39B | 11.76%1.34B | 11.90%1.31B | 10.51%1.27B |
| Total liabilityies and equity | 16.49%1.93B | 19.09%1.9B | 21.96%1.89B | 19.17%1.75B | 17.94%1.65B | 16.85%1.6B | 15.35%1.55B | 14.77%1.47B | 11.14%1.4B | 7.89%1.37B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.